Lifestyle Intervention for oVarian cancer Enhanced Survival - LIvES study ‐ GOG 0225

The LIvES study will be recruiting 1,070 ovarian cancer survivors nationally to participate in a lifestyle intervention supported by the Gynecologic Oncology Group and the National Cancer Institute. The main study objective is to determine if the lifestyle intervention group experiences improved quality of life and survival in comparison to the usual care group. Additional objectives of this study involve assessment of nutrients in your blood.

Who can participate?

  • Ovarian, Fallopian tube and Primary Peritoneal cancer survivors with a history of stage II-IV cancer
  • Completed consolidation treatment within the past 6 weeks to 6 1/2 months
  • No clinical evidence of persistent or recurrent disease
  • Willing to fill out study questionnaires and be able to be contacted repeatedly by telephone over the course of the study
  • No history of other chronic illness

What will I be asked to do?

To find a clinic near you participating in the
LIvES trial (GOG ‐ 0225) Please visit the
National Cancer Institute website,
or talk to your medical oncologist.